BioSig Technologies Signs Agreement to Conduct Pre Clinical Studies at UCLA MINNEAPOLIS, July 29, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM), a proprietary technology platform designed to improve the fidelity of...

BioSig Technologies, Inc. Appoints David Weild to Its Board of Directors as Audit Committee Chairman MINNEAPOLIS, May 26, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) today announced that it has appointed David Weild to the Board of Directors, effective immediately. Mr. Weild has...

BioSig Technologies to Present at the Marcum MicroCap Conference in New York on May 27 MINNEAPOLIS, May 20, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clarity of...

Michele Chin-Purcell, Ph.D., to Join BioSig Technologies as Vice President, Quality and Regulatory Affairs MINNEAPOLIS, May 11, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB:BSGM), a medical device company developing PURE EP(TM) a proprietary technology platform designed to improve the clarity of...

BioSig Executive Leadership to Attend Heart Rhythm Society's 36th Annual Scientific Sessions, May 13 - 16, 2015 in Boston, MA LOS ANGELES, April 28, 2015 (GLOBE NEWSWIRE) -- BioSig Technologies (OTCQB: BSGM) executive leadership will be attending the Heart Rhythm Society's 36th Annual Scientific Sessions from May 13 –...